APA (7th ed.) Citation

McLeskey, C., Gudin, J., Adler, J., Rockett, C., Jamindar, M., Rauck, R., . . . Mallick-Searle, T. (2023). Naloxegol (Movantik®) Provides Rapid and Sustained Improvement of Opioid-Induced Constipation Symptoms Irrespective of Opioid Dose. Pain management nursing, 24(2), 237. https://doi.org/10.1016/j.pmn.2023.02.016

Chicago Style (17th ed.) Citation

McLeskey, Charles, Jeffrey Gudin, Jeremy Adler, Carol Rockett, Mansi Jamindar, Richard Rauck, Lynn Webster, and Theresa Mallick-Searle. "Naloxegol (Movantik®) Provides Rapid and Sustained Improvement of Opioid-Induced Constipation Symptoms Irrespective of Opioid Dose." Pain Management Nursing 24, no. 2 (2023): 237. https://doi.org/10.1016/j.pmn.2023.02.016.

MLA (9th ed.) Citation

McLeskey, Charles, et al. "Naloxegol (Movantik®) Provides Rapid and Sustained Improvement of Opioid-Induced Constipation Symptoms Irrespective of Opioid Dose." Pain Management Nursing, vol. 24, no. 2, 2023, p. 237, https://doi.org/10.1016/j.pmn.2023.02.016.